Argent Biopharma Limited has released a press release.
MGC Pharma announces $1m Strategic Placement and $3m SPP
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Agreement Signed with Leading Peruvian Distributor
- Supply Agreement with THC Global for Canndeo Products
- MGC Pharma Crosses 2,000 Prescription Milestone
- Launch of New Product Line in Aus & NZ - Mercury Pharma
- First Shipment of CogniCann en route to Australia
Later from Argent Biopharma
- Security Purchase Plan- Offer Document
- 85% Increase in Order Volume of New Prescription Products
- Commercial Supply Deal Signed for First Products into Poland
- Binding Amendment to Supply Agreement with ONIX Brazil
- Patients Begin Treatment in Clinical Trial of CogniCann
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma